![]() ![]() The diversity among these companies encompasses large corporate offices (GSK), established and emerging companies (WuXi AppTec, Iroko Pharmaceuticals, Adaptimmune and Coriell Life Sciences), educational institutions (Vincera Institute, Thomas Jefferson University Hospitals), and related capital ventures (Phoenix IP Ventures and Ben Franklin Technology Partners) among others. As a result, the Navy Yard is a hub for attracting top talent in the life sciences fields with more than 2,500 employees in this sector working on the campus. The tenants span a wide variety of specialties including a large cluster of leading-edge companies like WuXi Advanced Therapies, devoted to cell and gene therapy. The Navy Yard is home to one of the highest concentration of privately leased life science space in the city of Philadelphia with more than 800,000 square feet. We are thrilled to celebrate WuXi’s success with the groundbreaking of this new building.” “The Navy Yard offers WuXi a unique environment to support the growth its company, and is a place where their employees thrive. As one of the first tenants within the Navy Yard’s community of R&D enterprises, WuXi AppTec has long been at the forefront of innovation in Philadelphia,” said John Grady, President of PIDC. “Philadelphia is one of the most dynamic life sciences and healthcare industry centers in the nation. The site, one of the largest facilities in the world for the GMP manufacturing of viral vectors, provides late phase/commercial capacity. Two years later, Liberty finished its second build-to-suit for the company, a 150,000 square foot facility located at 4701 League Island Boulevard. ![]() 26 th Street to accommodate the growing demand for non-viral cell therapy manufacturing. In 2014, WuXi ATU expanded into 55,000 square feet at 4000 S. In 2004 Liberty completed its first building at the Navy Yard for WuXi ATU at 4751 League Island Boulevard, comprised of 82,000 square feet housing its early phase clinical manufacturing and testing operations. In addition to the new facility, WuXi Advanced Therapies occupies three other Liberty buildings at the Navy Yard. “We congratulate WuXi on this announcement of its fourth cutting-edge facility at the Navy Yard, and look forward to the creation of additional highly-skilled, high-paying jobs in Philadelphia.” ![]() “WuXi’s continued growth in Philadelphia at the Navy Yard reinforces the city’s standing as one of the nation’s leading innovation hubs,” said City of Philadelphia Mayor Jim Kenney. WuXi Advanced Therapies was represented by Kyle Greiert and Greg Soffian from Savills Studley in the transaction. Expertly crafted wood elements will adorn vital points of entry creating a warmth and detail that contrasts the solidity and scale of the 95,000 square-foot structure. Spanning longer than a city block, it will feature ripples of concrete and glass, creating a vibrant, animated urban façade. The new building at 400 Rouse Boulevard, designed by DIGSAU, anchors the central intersection of Rouse and League Island Boulevards. “WuXi’s facility in the Navy Yard has grown from one to a campus of four buildings, and employment here has increased from 150 people to more than 600 people and growing.” WuXi will more than double our testing capacity to support our cell and gene therapy clients,” says Felix Hsu, SVP and Global Head of Advanced Therapies. “The market demands for testing are increasing very quickly in advanced therapies. With their fourth building soon to be underway, WuXi ATU’s growth offers an excellent example of the Navy Yard’s appeal to leading-edge companies and its unique ability to attract and retain knowledgeable workers as well as accommodate long-term business expansion.” “Their continued success has helped to pave the way for creating one of the most highly concentrated clusters of privately leased life science space in Philadelphia. “WuXi was one of the first companies to locate to the Navy Yard more than fourteen years ago and throughout that time our strong partnership will have produced four cutting-edge facilities,” said Brian Cohen, vice president and market officer for Liberty Property Trust. Project Rendering at the intersection of Rouse Blvd. When the new building is complete in late 2019, WuXi ATU will become Liberty’s largest tenant in the campus, occupying in excess of 380,000 square feet of space. The new facility located at 400 Rouse Boulevard, designed to achieve LEED® certification, will be the fourth building that WuXi ATU occupies at the Navy Yard and the third build-to-suit developed by Liberty for the company. Liberty Property Trust and Synterra Partners is set to break ground early next month on a 95,000 square foot build-to-suit office and laboratory building for WuXi AppTec’s Advanced Therapies Business Unit (WuXi ATU) at the Navy Yard. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |